Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates.
about
A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replicationAntigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cellsA new class of multimerization selective inhibitors of HIV-1 integraseMitochondrial glutaminase release contributes to glutamate-mediated neurotoxicity during human immunodeficiency virus-1 infectionA synthetic HIV-1 subtype C backbone generates comparable PR and RT resistance profiles to a subtype B backbone in a recombinant virus assayNon-catalytic site HIV-1 integrase inhibitors disrupt core maturation and induce a reverse transcription block in target cellsDecreased phenotypic susceptibility to etravirine in patients with predicted genotypic sensitivityDefining the fitness of HIV-1 isolates with dual/mixed co-receptor usageRecapitulating Cross-Species Transmission of Simian Immunodeficiency Virus SIVcpz to Humans by Using Humanized BLT Mice.Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses.TaqMan real-time reverse transcription-PCR and JDVp26 antigen capture enzyme-linked immunosorbent assay to quantify Jembrana disease virus load during the acute phase of in vivo infection.Rapid dissociation of HIV-1 from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high level of infectivity of virions.Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry.Stochastic theory of early viral infection: continuous versus burst production of virions.Viral dynamics during primary simian immunodeficiency virus infection: effect of time-dependent virus infectivity.The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates.Analysis of infectious virus clones from two HIV-1 superinfection cases suggests that the primary strains have lower fitness.Subtype-associated differences in HIV-1 reverse transcription affect the viral replication.Intercellular adhesion molecule 1 promotes HIV-1 attachment but not fusion to target cells.The level of reverse transcriptase (RT) in human immunodeficiency virus type 1 particles affects susceptibility to nonnucleoside RT inhibitors but not to lamivudineQuantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors.Human semen contains exosomes with potent anti-HIV-1 activity.Mycobacterial phosphatidylinositol mannoside 6 (PIM6) up-regulates TCR-triggered HIV-1 replication in CD4+ T cells.Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in Argentina.SiRNA-induced mutation in HIV-1 polypurine tract region and its influence on viral fitness.A novel method for the measurement of hepatitis C virus infectious titres using the IncuCyte ZOOM and its application to antiviral screeningEfficiency of human immunodeficiency virus type 1 postentry infection processes: evidence against disproportionate numbers of defective virions.Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus Population.Acute BVDV-2 infection in beef calves delays humoral responses to a non-infectious antigen challenge.HIV-1 clade B and C isolates exhibit differential replication: relevance to macrophage-mediated neurotoxicity.HIV-1 Integrates Widely throughout the Genome of the Human Blood Fluke Schistosoma mansoni.Maraviroc and other HIV-1 entry inhibitors exhibit a class-specific redistribution effect that results in increased extracellular viral load.Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection.HIV-1 resistance to maraviroc conferred by a CD4 binding site mutation in the envelope glycoprotein gp120A cis-acting element in retroviral genomic RNA links Gag-Pol ribosomal frameshifting to selective viral RNA encapsidation.Clinical significance of human immunodeficiency virus type 1 replication fitness.The human immunodeficiency virus type 1 envelope confers higher rates of replicative fitness to perinatally transmitted viruses than to nontransmitted virusesMultifaceted mechanisms of HIV inhibition and resistance to CCR5 inhibitors PSC-RANTES and Maraviroc.CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic.A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains
P2860
Q25255588-0AAFF9B3-C818-4DFB-9170-12B8565E5630Q27320687-60119247-DA4A-47A4-B09B-CBB8346D89B1Q27683994-22143647-D4E4-4C3D-879E-ED1FDAA0DAB8Q28396045-3C021BC4-B4E8-4B51-A284-0CCE63DB50E7Q28478253-649EB6C4-9533-43EC-9A68-B8FB191DF2D6Q28536951-B3853826-AE1C-44F6-A045-BCF708A9B86DQ28540368-FAF7497B-CEEB-4587-9253-496C8C9EBC07Q30278577-957B7D85-A749-4CA5-BC4C-1E8BE3A5B4E3Q30389334-4E9393A9-98C1-4449-B0EA-EEBDCD1AAB63Q30480959-9A09C91F-89BE-4193-A83D-EE298807DB14Q33226690-8D334732-7D15-4FA0-B5B8-4BD03FFC9AC5Q33676520-F1900171-8A41-4D67-9DA7-E58A484118F9Q33788743-9AAE081B-DCC9-4C57-9E55-CDA5B03FE1C2Q33815539-4BF77943-71E0-4AAB-912D-F06A51199AC0Q33826587-DB73ABF7-CDD5-4393-AB3F-0DC79927A021Q33884059-9FB34A1E-AD30-49EB-A6E0-355B51D09164Q34053505-DE863668-01E4-408A-9C29-43E7D5F954A2Q34243467-8A22A372-7D46-4D9F-AD42-B7DF488B1D54Q34412803-CF2FDAFA-81A7-41EA-88C9-F1536347327DQ34434653-F4A2BB48-12E1-4DD7-9BDD-DF73A98B8686Q34507124-360F8E5E-25A3-4C94-888D-153FC309032DQ34578814-2A2A3E25-EF85-4E1F-935A-275A08E18532Q35055182-09ED7CC1-B604-44D0-AA07-7A67F1D1A85CQ35146589-9C4F40DF-80C6-433F-B59E-D7AEDD1212E7Q35362902-3551786D-0FD8-4004-8DBF-1D367D1C0518Q35542987-9B196D79-181F-458A-9F6B-15BC13D37116Q35785356-78C88759-EC4F-47AC-83AA-8ADB719C03F1Q35875253-CCDDDB43-CCCE-4ACB-9491-9F3BB81E2341Q36067666-94D0FCB2-3277-4383-8A8D-F6997509A2CFQ36124813-52D9AFB2-7B7A-4809-9FC6-4F9A9906A760Q36169656-25F133A9-C428-4A7C-AC8E-C43E9D0D9D6CQ36171658-D30A0CCD-E84A-44E8-A203-CC39607FCF5AQ36459268-9BAEE450-1343-4234-BFB6-1AB86C3A1B27Q36559608-CD0D650C-47C0-4122-BD01-0818476C2CC5Q36653089-28E8AA97-0E18-42FE-B578-D333832F11CAQ36969857-F24C04FC-6091-495C-8D76-48EE356009EAQ36974671-9E37F1C2-4950-4545-A781-6461A53AD5EAQ37026646-AC925C17-A754-405B-9BE1-8A1D9113CF59Q37191866-8AB26B6E-0421-463B-9D09-93C0E0A13E8EQ37410812-F20362EE-9E09-4A08-8F3B-6620BD747135
P2860
Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Relationships between infectio ...... iciency virus type 1 isolates.
@en
Relationships between infectio ...... iciency virus type 1 isolates.
@nl
type
label
Relationships between infectio ...... iciency virus type 1 isolates.
@en
Relationships between infectio ...... iciency virus type 1 isolates.
@nl
prefLabel
Relationships between infectio ...... iciency virus type 1 isolates.
@en
Relationships between infectio ...... iciency virus type 1 isolates.
@nl
P2093
P2860
P1433
P1476
Relationships between infectio ...... iciency virus type 1 isolates.
@en
P2093
Andre J Marozsan
Awet Abraha
Dawn Moore
Eric J Arts
Erika Fraundorf
Heather Baird
Immaculate Nankja
Ryan Troyer
P2860
P304
11130-11141
P356
10.1128/JVI.78.20.11130-11141.2004
P407
P577
2004-10-01T00:00:00Z